Endo Manufacturing Co., Ltd.

As of June 30, 2026, Endo Manufacturing Co., Ltd. carries a market capitalization of 9.51B, placing it among publicly traded companies globally. Its enterprise value stands at 148.13M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Endo Manufacturing Co., Ltd.'s next confirmed earnings release is scheduled for November 5, 2026.

As of June 30, 2026, Endo Manufacturing Co., Ltd. has 8.81M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Endo Manufacturing Co., Ltd. maintains a current ratio of 4.77, meaning it holds 4.8x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

As of the close on October 22, 2026, Endo Manufacturing Co., Ltd.'s stock has declined approximately 16.58% over the past 52 weeks. The 50-day moving average sits at 1,087.58, while the 200-day moving average is 1,134.32.

As of June 30, 2026, Endo Manufacturing Co., Ltd. holds 9.40B in cash and equivalents against 43.35M in total debt, resulting in a net debt position of -8.86B. Total book value stands at 23.22B, with working capital of 13.50B providing operational flexibility.